Typical Dose 50-125 ug
Duration 8h - 12h
Interaction Risk Unknown
Community · single experiences
Effect Profile
Describes the acute effect. This profile does not influence the OpenMind Score.
No effect profiles yet. Describe the acute effect without changing the long-term score.
Please log in to add effect details
Log inDescription
1B-LSD (1-butanoyl-lysergic acid diethylamide) is an LSD analogue which appears to be about as potent as 1P-LSD (slightly more potent than LSD) and has a slightly shorter duration than that of LSD, again thought to be about the same as 1P-LSD. Released in late 2018, and marketed agressively as a replacement for 1P-LSD. 1B-LSD does not yet have a clearly established safety profile,
Effects & Dosing
Dosage
Oral
| Light | Common | Strong |
|---|---|---|
| 25-50 ug | 50-125 ug | 125-250 ug |
Duration
Oral
Onset 45 min - 1h 30m
Total Duration 8h - 12h
After Effects 6h - 24h
Safety & Risks
Safer Use
- NOTE: At the time of this chemical's release, the manufacturers claimed 1B-LSD was expected to be slightly less potent than 1P-LSD, supposedly owing to the increased mass of the butanoyl group over the propionyl group, however anecdotes seem to indicate approximate equipotency to 1P-LSD.
Community Experiences
Share a single experience — does not affect the OpenMind Score.
Comments
Please log in to comment
Log inPlease sign in to suggest edits.
Everything in OpenMind
Track your use, check combinations and find safer use tips – even offline.
No comments yet.